XML 60 R54.htm IDEA: XBRL DOCUMENT v3.25.2
Goodwill and Intangible Assets (Additional Information) (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
May 31, 2023
Aug. 22, 2022
Jul. 11, 2022
Goodwill [Line Items]                
Goodwill $ 17,905   $ 17,905   $ 17,905      
Amortization expense 6,500 $ 6,400 13,022 $ 12,880        
Future amortization expense, remainder of 2025 13,200   13,200          
Future amortization expense, 2026 26,300   26,300          
Future amortization expense, 2027 26,300   26,300          
Future amortization expense, 2028 26,300   26,300          
Future amortization expense, 2029 26,300   26,300          
Future amortization expense, thereafter 74,300   74,300          
Goodwill, impairment losses     0   0      
Basilea                
Goodwill [Line Items]                
Upfront fee         4,000      
In-process research and development                
Goodwill [Line Items]                
Amortization expense     0   0      
Acquired Finite-Lived Intangible Asset, Residual Value 2,600   2,600          
In-process research and development | XACDURO                
Goodwill [Line Items]                
Intangible assets pertain to product rights and developed technologies           $ 68,700    
La Jolla Pharmaceutical Company                
Goodwill [Line Items]                
Goodwill             $ 6,400  
Intangible assets pertain to product rights and developed technologies 151,000   151,000          
Entasis                
Goodwill [Line Items]                
Goodwill               $ 11,500
Intangible assets pertain to product rights and developed technologies 106,700   106,700          
Entasis | Collaboration agreement                
Goodwill [Line Items]                
Intangible assets pertain to product rights and developed technologies         $ 35,400      
Entasis | In-process research and development                
Goodwill [Line Items]                
Intangible assets pertain to product rights and developed technologies $ 71,300   $ 71,300